Form 4 for CRMD CorMedix Inc.
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-02 · accession 0001213900-25-118433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-04 | 2025-12-02 | CRMD | Dillione Janet | Dir | S - Sale+OE | $10.00 | -46.7K | 48.5K | -49% | -$466.6K |
| DM | 2025-12-04 | 2025-12-02 | CRMD | Dillione Janet | Dir | M - OptEx | $3.96 | +46.7K | 95.1K | +96% | +$184.8K |
| DM | 2025-12-04 | 2025-12-02 | CRMD | Dillione Janet | Dir | M - OptEx | $0.00 | -46.7K | 5,000 | -90% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-02 | S | D | 46,657 | $10.00 | 48,473 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-02 | M | A | 12,210 | $4.03 | 60,683 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-02 | M | A | 15,124 | $4.43 | 75,807 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-02 | M | A | 19,323 | $3.55 | 95,130 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-12-02 | M | D | 15,124 | $0.00 | 0 | D | $4.43 · — to 2033-01-14 | 15,124 Common Stock | (F2) These options were granted on 01/14/2023. These options are fully vested. |
| 6 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-12-02 | M | D | 12,210 | $0.00 | 0 | D | $4.03 · — to 2032-02-22 | 12,210 Common Stock | (F1) These options were granted on 02/22/2022. These options are fully vested. |
| 7 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-12-02 | M | D | 19,323 | $0.00 | 5,000 | D | $3.55 · — to 2034-03-05 | 19,323 Common Stock | (F3) These options were granted on 03/05/2024. These options are fully vested. |